Incubated and backed by LCatterton, Tally Health, a revolutionary consumer biotechnology company tackling the way we age, closed a $10 million seed round of funding led by Forerunner Ventures.
WHO: Tally Health, a consumer biotechnology company aimed at changing the way we age, launched in February. Co-founded by Dr. David Sinclair and L Catterton partner and serial entrepreneur Whitney Casey, one of the world’s foremost experts on aging and human longevity, Tally Health develops proprietary, science-backed technology to improve health span and extend longevity at the cellular level. Individuals can learn their biological age, or TallyAge, with Tally's easy-to-use, at-home, noninvasive cheek swab test. The company uses a proprietary biological aging clock and a next-generation DNA analysis procedure to analyze genetic modifications that change throughout aging and reflect lifestyle habits.
WHY: The new capital will support Tally Health as they expand research and development of new products, additional features, and technology integrations to allow users to seamlessly integrate their TallyAge feedback into their daily lifestyle through the digital member experience. Funds will also be allocated toward various technical, business, and strategic development efforts as the company scales.
IN THEIR OWN WORDS: “Longevity presents a remarkable, underserved opportunity, particularly in the context of its fundamental, universal importance—everyone ages, and increasingly savvy, health-conscious generations are highly motivated to have more agency over the process and ultimately live a more fulfilling life,” said Kirsten Green, founding partner at Forerunner. “The Tally Health team is in a category-defining position to open up access to scientific breakthroughs that not just slow aging, but can even help reverse it."
“This financing underscores the significant and growing consumer interest in healthspan and longevity. I am pleased to see our 270,000+ pre-launch waitlist converting as we attract new members, investors, and celebrities who believe in our mission to increase healthspan, drive impactful lifestyle changes, and extend human healthspan and longevity,” said Melanie Goldey, CEO of Tally Health. “I am thrilled to partner with Kirsten who brings her passion for mission-oriented companies like ours, as well as deep strategic and operational knowledge, to our Board as we rapidly expand our reach, access, and product offering.”
"We founded Tally Health based on pure demand for more science-backed longevity innovations for consumers. We are able to scale learnings from breakthrough epigenetic research with our own proprietary technologies to bring the science in-home for our members," said Whitney Casey, co-founder of Tally Health and Partner at L Catterton. "There is a growing global consumer interest in evaluating health through the lens of longevity, and Tally Health's continued growth will propel the AgeTech sector forward."
DETAILS:
